发明名称 |
AGLYCOSYLATED HUMAN ANTIBODY AND FUSION PROTEIN AND USES THEREOF |
摘要 |
<p>The invention is a method for reducing the effector functions of a therapeutic neutralizing antibody by administering to the afflicted subject an effective amount of an engineered aglycosylated human monoclonal antibody containing an engineered Fc region, wherein aglycosylation of the Fc region prevents therapeutic antibody-mediated cell activation, inflammation, Clq binding to the antibody and antibody triggered classical pathway activation.</p> |
申请公布号 |
WO2013102123(A2) |
申请公布日期 |
2013.07.04 |
申请号 |
WO2012US72142 |
申请日期 |
2012.12.28 |
申请人 |
NOVELMED THERAPEUTICS, INC. |
发明人 |
BANSAL, REKHA |
分类号 |
A61K39/395;A61P29/00;C07K16/22;C07K16/24;C07K16/28 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|